Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence

被引:23
作者
Bellmann, R
Egger, P
Wiedermann, CJ
机构
[1] Univ Innsbruck, Dept Internal Med, Intens Care Unit, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Clin Pharmacokinet Unit, Med Intens Care Res Lab, A-6020 Innsbruck, Austria
关键词
D O I
10.1086/374876
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1500 / 1501
页数:2
相关论文
共 24 条
  • [1] DOSE-DEPENDENT ANTIFUNGAL ACTIVITY AND NEPHROTOXICITY OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN EXPERIMENTAL PULMONARY ASPERGILLOSIS
    ALLENDE, MC
    LEE, JW
    FRANCIS, P
    GARRETT, K
    DOLLENBERG, H
    BERENGUER, J
    LYMAN, CA
    PIZZO, PA
    WALSH, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) : 518 - 522
  • [2] Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion
    Anaissie, EJ
    Mattiuzzi, GN
    Miller, CB
    Noskin, GA
    Gurwith, MJ
    Mamelok, RD
    Pietrelli, LA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 606 - 611
  • [3] Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration
    Bellmann, R
    Egger, P
    Gritsch, W
    Bellmann-Weiler, R
    Joannidis, M
    Kaneider, N
    Dunzendorfer, S
    Wiedermann, CJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) : 671 - 681
  • [4] Review of comparative studies between conventional and liposomal amphotericin B (Ambisome®) in neutropenic patients with fever of unknown origin and patients with systemic mycosis
    Blau, IW
    Fauser, AA
    [J]. MYCOSES, 2000, 43 (9-10) : 325 - 332
  • [5] AmBisome (Liposomal amphotericin B): A comparative review
    Boswell, GW
    Buell, D
    Bekersky, I
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (07) : 583 - 592
  • [6] Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant
    Bowden, RA
    Cays, M
    Gooley, T
    Mamelok, RD
    vanBurik, JA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) : 1208 - 1215
  • [7] Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography
    Egger, P
    Bellmann, R
    Wiedermann, CJ
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 760 (02): : 307 - 313
  • [8] Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia
    Fleming, RV
    Kantarjian, HM
    Husni, R
    Rolston, K
    Lim, J
    Raad, I
    Pierce, S
    Cortes, J
    Estey, E
    [J]. LEUKEMIA & LYMPHOMA, 2001, 40 (5-6) : 511 - 520
  • [9] Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia
    Frothingham, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 896 - 897
  • [10] Pharmacokinetics of liposomal amphotericin B (AmBisome) in critically ill patients
    Heinemann, V
    Bosse, D
    Jehn, U
    Kahny, B
    Wachholz, K
    Debus, A
    Scholz, P
    Kolb, HJ
    Wilmanns, W
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1275 - 1280